HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $33 Price Target
Benzinga Newsdesk 12 months ago
NewsPrice TargetReiterationAnalyst Ratings
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $33 price target.
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and maintains $33 price target.